WA
KITE

WFG Advisors’s Kite Pharma, Inc. KITE Stock Holding History

WFG Advisors’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$6K Buy
+58
New +$4.73K ﹤0.01% 1270
2017
Q1 		– Sell
-59
Closed -$3K – 1748
2016
Q4 		$3K Buy
+59
New +$2.89K ﹤0.01% 1390

Other funds holding KITE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

WFG Advisors's KITE Position: Q2 2017 in Review

WFG Advisors opened a new position in Kite Pharma, Inc. (KITE) in Q2 2017: 58 shares worth $6K. The stake represents ﹤0.01% of the portfolio and ranks #1270 among its holdings. This is a return to the name: WFG Advisors previously reported a position in KITE as recently as Q4 2016.

WFG Advisors first reported a position in KITE in Q4 2016 and has held it in 2 quarters since. 220 funds tracked by Wall St. Rank hold KITE as of Q2 2017.

  • WFG Advisors held 58 shares of Kite Pharma, Inc. worth $6K as of Q2 2017.
  • Kite Pharma, Inc. was a new WFG Advisors position in Q2 2017.
  • Kite Pharma, Inc. made up ﹤0.01% of WFG Advisors's portfolio in Q2 2017, its #1270 holding.
  • WFG Advisors first reported a position in Kite Pharma, Inc. in Q4 2016 and has held it in 2 quarters since.
  • 220 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q2 2017.

Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.